Rock Springs Capital Management LP - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 59 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,926,000
-24.4%
368,9590.0%0.06%
-12.5%
Q1 2022$2,546,000
-44.6%
368,9590.0%0.06%
-39.6%
Q4 2021$4,594,000
-59.4%
368,959
+1.8%
0.11%
-55.5%
Q3 2021$11,324,000
+3.4%
362,359
-5.2%
0.24%
+10.2%
Q2 2021$10,947,000
-33.2%
382,359
+1.1%
0.22%
-39.7%
Q1 2021$16,387,000
-36.4%
378,195
+4.9%
0.36%
-34.6%
Q4 2020$25,784,000
+137.5%
360,363
+0.0%
0.55%
+98.9%
Q3 2020$10,855,000360,2630.28%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$69,274,0001.12%
Baker Brothers Advisors 10,123,824$69,854,0000.40%
HHLR ADVISORS, LTD. 583,333$4,025,0000.08%
Rock Springs Capital Management LP 368,959$2,546,0000.06%
PDT Partners, LLC 71,822$496,0000.04%
Virtus ETF Advisers LLC 13,048$90,0000.04%
Corton Capital Inc. 10,918$75,0000.03%
GSA CAPITAL PARTNERS LLP 23,201$160,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 24,238$167,0000.01%
IndexIQ Advisors LLC 56,750$392,0000.01%
View complete list of PRELUDE THERAPEUTICS INC shareholders